Michelle McMurry-Heath, BIO CEO (BIO)

BIO and a string of CEOs is­sue a call for FDA in­de­pen­dence and against sci­ence-by-press-re­lease

It ap­pears to be open let­ter week in biotech.

On Sun­day, Scripps Re­search’s Er­ic Topol penned a scathing let­ter in Med­scape call­ing for FDA com­mis­sion­er Stephen Hahn to re­sign af­ter a se­ries of al­leged mis­steps and po­lit­i­cal con­ces­sions.  And to­day, in a care­ful­ly-word­ed piece, the head of BIO and eight well-known biotech CEOs is­sued a call for the FDA’s in­de­pen­dence and for biotechs — with the world spot­light on them — to be on their best be­hav­ior.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Vice President

Alexandria Real Estate Equities

San Francisco, CA, USA